Windtree Therapeutics, Inc. announced John Hamill has been appointed as Chief Financial Officer. In this role, Mr. Hamill will help accelerate key initiatives to advance the Company's business, financial planning, and shareholder value. He most recently provided consulting services to various life science companies, headed up finance at Trevena, Inc. John Hamill is replacing Windtree's former CFO, John Tattory who is leaving to pursue other opportunities.